Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 57, 5300-5304, December 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mansat, V.
Right arrow Articles by Jaffrézou, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mansat, V.
Right arrow Articles by Jaffrézou, J.-P.

The Protein Kinase C Activators Phorbol Esters and Phosphatidylserine Inhibit Neutral Sphingomyelinase Activation, Ceramide Generation, and Apoptosis Triggered by Daunorubicin1

Véronique Mansat, Guy Laurent, Thierry Levade, Ali Bettaïeb and Jean-Pierre Jaffrézou2

Contrat Jeune Formation, Institut National de la Santé et de la Recherche Médicale 9503, Centre Claudius Régaud, Toulouse Cedex 31052 [V. M., G. L., A. B., J-P. J.]; Laboratoire de Biochimie Médicale, Institut National de la Santé et de la Recherche Médicale U466, Centre Hospitalier Universitaire Rangueil, Toulouse 31403 [T. L.]; and Service d'Hématologie Centre Hospitalier Universitaire Purpan, Toulouse 31059 [G. L.], France

To address the role of protein kinase C (PKC) in the regulation of ceramide production, we evaluated the impact of the PKC activators 12-O-tetradecanoylphorbol-13-acetate and phosphatidylserine on the apoptotic signaling pathway triggered by the chemotherapeutic drug daunorubicin. Treatment of U937 and HL-60 cells with 0.5–1 µM daunorubicin induced a greater than 30% activation of neutral sphingomyelinase activity within 4–10 min with concomitant sphingomyelin hydrolysis and ceramide generation. Activation of PKC by 12-O-tetradecanoylphorbol-13-acetate and phosphatidylserine inhibited daunorubicin-induced neutral sphingomyelinase activation, sphingomyelin hydrolysis, ceramide generation, and apoptosis. The apoptotic response could be restored by the addition of 25 µM cell-permeant C6-ceramide. In conclusion, PKC emerges as a potentially critical negative regulator of the anthracycline-activated sphingomyelin-ceramide apoptotic pathway.

1 This study was supported in part by Grant 96003115 from La Fédération Nationale des Centres de Lutte Contre le Cancer (to J-P. J. and T. L.); by a grant from the Conseil Régional Midi-Pyrées (to T. L. and J-P. J.); by l'Association pour la Recherche sur le Cancer Grants 6749 (to G. L.), 3002 (to T. L.), and 2069 (to J-P. J.); and by a grant from La Ligue Nationale Contre le Cancer (to G. L.). V. M. is the recipient of an Institut National de la Santé et de la Recherche Médicale fellowship.

2 To whom requests for reprints should be addressed, at CJF INSERM 9503, Centre Claudius Régaud, 20 rue du Pont St. Pierre, Toulouse Cedex 31052 France. E-mail: jaffrezou@regaud-tlse.fnclcc.fr.

Received 5/ 1/97. Accepted 10/ 3/97.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
O. Humbert, I. Achour, D. Lautier, G. Laurent, and B. Salles
hMSH2 expression is driven by AP1-dependent regulation through phorbol-ester exposure
Nucleic Acids Res., October 1, 2003; 31(19): 5627 - 5634.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
M. Minamino, I. Sakaguchi, T. Naka, N. Ikeda, Y. Kato, I. Tomiyasu, I. Yano, and K. Kobayashi
Bacterial ceramides and sphingophospholipids induce apoptosis of human leukaemic cells
Microbiology, August 1, 2003; 149(8): 2071 - 2081.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Bezombes, A. de Thonel, A. Apostolou, T. Louat, J.-P. Jaffrezou, G. Laurent, and A. Quillet-Mary
Overexpression of Protein Kinase Czeta Confers Protection Against Antileukemic Drugs by Inhibiting the Redox-Dependent Sphingomyelinase Activation
Mol. Pharmacol., December 1, 2002; 62(6): 1446 - 1455.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Maddens, A. Charruyer, I. Plo, P. Dubreuil, S. Berger, B. Salles, G. Laurent, and J.-P. Jaffrezou
Kit signaling inhibits the sphingomyelin-ceramide pathway through PLCgamma 1: implication in stem cell factor radioprotective effect
Blood, July 30, 2002; 100(4): 1294 - 1301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Humbert, T. Hermine, H. Hernandez, T. Bouget, J. Selves, G. Laurent, B. Salles, and D. Lautier
Implication of Protein Kinase C in the Regulation of DNA Mismatch Repair Protein Expression and Function
J. Biol. Chem., May 10, 2002; 277(20): 18061 - 18068.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Laurent and J.-P. Jaffrezou
Signaling pathways activated by daunorubicin
Blood, August 15, 2001; 98(4): 913 - 924.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Fettucciari, E. Rosati, L. Scaringi, P. Cornacchione, G. Migliorati, R. Sabatini, I. Fetriconi, R. Rossi, and P. Marconi
Group B Streptococcus Induces Apoptosis in Macrophages
J. Immunol., October 1, 2000; 165(7): 3923 - 3933.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Allouche, R. S. Charrad, A. Bettaieb, C. Greenland, C. Grignon, and F. Smadja-Joffe
Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells
Blood, August 1, 2000; 96(3): 1187 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Ferraro, L. Quemeneur, A.-F. Prigent, C. Taverne, J.-P. Revillard, and N. Bonnefoy-Berard
Anthracyclines Trigger Apoptosis of Both G0-G1 and Cycling Peripheral Blood Lymphocytes and Induce Massive Deletion of Mature T and B Cells
Cancer Res., April 1, 2000; 60(7): 1901 - 1907.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Kondo, T. Matsuda, M. Tashima, H. Umehara, N. Domae, K. Yokoyama, T. Uchiyama, and T. Okazaki
Suppression of Heat Shock Protein-70 by Ceramide in Heat Shock-induced HL-60 Cell Apoptosis
J. Biol. Chem., March 17, 2000; 275(12): 8872 - 8879.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. M.-D. Mas, C. Bezombes, A. Quillet-Mary, A. Bettaïeb, A. D. T. D'orgeix, G. Laurent, and J.-P. Jaffrézou
Implication of Radical Oxygen Species in Ceramide Generation, c-Jun N-Terminal Kinase Activation and Apoptosis Induced by Daunorubicin
Mol. Pharmacol., November 1, 1999; 56(5): 867 - 874.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Laouar, D. Glesne, and E. Huberman
Involvement of Protein Kinase C-beta and Ceramide in Tumor Necrosis Factor-alpha -induced but Not Fas-induced Apoptosis of Human Myeloid Leukemia Cells
J. Biol. Chem., August 13, 1999; 274(33): 23526 - 23534.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Bettaïeb, I. Plo, V. Mansat-De Mas, A. Quillet-Mary, T. Levade, G. Laurent, and J.-P. Jaffrézou
Daunorubicin- and Mitoxantrone-Triggered Phosphatidylcholine Hydrolysis: Implication in Drug-Induced Ceramide Generation and Apoptosis
Mol. Pharmacol., January 1, 1999; 55(1): 118 - 125.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. A. Wagner, G. R. Buettner, L. W. Oberley, C. J. Darby, and C. P. Burns
Myeloperoxidase Is Involved in H2O2-induced Apoptosis of HL-60 Human Leukemia Cells
J. Biol. Chem., July 14, 2000; 275(29): 22461 - 22469.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Paris, H. Grassme, A. Cremesti, J. Zager, Y. Fong, A. Haimovitz-Friedman, Z. Fuks, E. Gulbins, and R. Kolesnick
Natural Ceramide Reverses Fas Resistance of Acid Sphingomyelinase-/- Hepatocytes
J. Biol. Chem., March 9, 2001; 276(11): 8297 - 8305.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1997 by the American Association for Cancer Research.